Searchable abstracts of presentations at key conferences in endocrinology

ea0034p391 | Thyroid | SFEBES2014

Anti-thyroid drugs as treatment for neutropenia in Graves’ thyrotoxicosis

Aggarwal N , Saqib W , Fretwell T , Summerfield G , Razvi S

Background: Neutropenia due to anti-thyroid drug (ATD) therapy in Graves’ disease is rare but is well recognised. However, the effect of hyperthyroidism, prior to and after ATD therapy, on absolute neutrophil counts in patients with Graves’ disease is unclear.Methods: We noted neutrophil levels in consecutive patients with newly diagnosed Graves’ thyrotoxicosis in 2010–2013. We further noted neutrophil levels once patients had been tr...

ea0029p619 | Diabetes | ICEECE2012

Cardiac dyssynchrony as a pathophysiological mechanism of heart failure development and progression in type 2 diabetic patients

Lopin D. , Lopina N. , Rodionova J. , Vlasenco M. , Volkov D.

Objectives: Diabetes mellitus (DM) is an independent predictor of new onset heart failure (HF) and adverse outcomes among patients with already existing HF. However mechanisms leading to impaired cardiac performance due to DM are still unclear.The purpose of investigation was to assess the influence of cardiac dyssynchrony (DYS) on systolic and diastolic function in patient with type 2 diabetes mellitus (T2DM) with concomitant stable coronary artery dise...

ea0029p1686 | Thyroid (non-cancer) | ICEECE2012

Primary and secondary autoimmune thyroiditis in rheumatoid patients

Odin V. , Tyrenko V. , Tzygan E. , Blohin M. , Avtandilashvily N.

Aim: Studying of features autoimmune thyroiditis associated with rheumatoid arthritis (AIT/RA).Methods and materials: Twenty-nine women with AIT/RA were examined. Study design included: special protocol of anamnesis, sonography of thyroid gland, evaluation of thyroglobulin antibodies (Tg-Ab), thyreoperoxidase antibodies (TPO-Ab), the thyroid hormones (T3, T4) and TSH in serum. Two groups of patients have been allocated: I group (...

ea0065p148 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

An audit on a teenage and young adult (TYA) neuro-oncology and late effects clinic

Chow Anthea , Zammitt Nicola N , Wright Rohana J

Introduction: Due to improved cancer survival rates, a rising number of CNS cancer survivors face late effects of therapy, such as hormone deficiencies. During adolesecence and young adulthood, specialised transition services are needed to cater for young peoples complex health needs and general needs, such as achieving independence. This study therefore audited a Teenage & Young Adult (TYA) neuro-oncology late effects clinic to identify areas of good practice and areas fo...

ea0037gp.09.05 | Nuclear receptors and signalling | ECE2015

Neuroprotective effects of 17β-oestradiol: a therapeutic potential drug for Alzheimer's disease

Kumar Pardeep , Kale R K , Baquer N Z

Objectives: Alzheimer’s disease (AD) is the most common form of dementia in the elderly. AD is characterized by the presence of amyloid plaques which are formed from deposits of β-amyloid protein (Ab). These changes increase during menopausal condition in females when the level of oestradiol (E2) is decreased. The aim of the present study was to determine the effect of neuropeptide, neurokinin B (NKB) and amyloid beta fragment Aβ (25–35) on E<sub...

ea0037ep1047 | Thyroid (non-cancer) | ECE2015

TPOAb as an autoimmune response or index of thyroid hypofunction in breast cancer?

Smyth Peter , McDermott E W M , O'Higgins N J

The observed association between thyroid disorders and breast cancer has provoked many investigations. One area where there is some, although far from universal, agreement is the finding of an increased prevalence of anti-thyroid autoantibodies in breast cancer patients compared to controls. Whether this is a feature of a generalised autoimmune response to breast cancer, or provoked by the enzyme thyroid peroxidase acting as an autoantigen, remains unclear. In this study we lo...

ea0032p503 | Endocrine disruptors | ECE2013

Protective potential of 17-beta-estradiol on membrane linked functions in aging female rats: a behavioral, biochemical and ultrastructural study

Kumar Pardeep , Kale R K , Baquer N Z

Background: Alzheimer’s disease (AD) is the most common form of dementia in the elderly. AD is characterized by the presence of amyloid plaques which are formed from deposits of b-amyloid protein (Ab). These changes increase during menopausal condition in females when the level of estradiol is decreased.Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetyl...

ea0029p778 | Endocrine tumours and neoplasia | ICEECE2012

GPR30, the non classical membrane G protein related estrogen receptor (GPER), is overexpressed in human seminoma and promotes seminoma cell proliferation.

Chevalier N. , Paul-Bellon R. , Vega A. , Bouskine A. , Fenichel P.

Background: Testicular germ cell tumours are the most frequent cancer of young men. While pathogenesis and reasons of an increasing incidence all over the world remain unknown, epidemiological and clinical data have suggested that fetal exposure to environmental endocrine disruptors (EEDs), especially with estrogenic effects, could participate to testicular germ cell carcinogenesis. However, EEDs (like bisphenol A) are often weak ligands for classical nuclear estrogen receptor...

ea0024oc2.5 | Oral Communications 2 (Brief Communications) | BSPED2010

Correlation of clinical and functional data to predict pubertal outcome in PAIS

Miles H , Lek N , Mooslehner K , Bunch T , Davies J

Introduction:: Advances in MDT working in Disorders of Sexual Development (DSD) are supported by activities which call for national and international collaborations. In the EuroDSD programme we are collecting clinical data and performing functional studies to assess the pubertal outcome of PAIS patients raised male.Methods: Clinical information including birth phenotype, surgery, medication and pubertal outcome, from 16 post pubertal PAIS patients with k...

ea0011p678 | Reproduction | ECE2006

Changes in GnRH gene expression in the medial basal hypothalamus of rhesus macaques across the menstrual cycle

Urbanski HF , Noriega N , Garyfallou VT , Downs JL , Kohama SG

Rhesus macaques, like humans, express two molecular forms of gonadotropin-releasing hormone (GnRH-I and GnRH-II). Although the role of GnRH-I in the control of the reproductive axis is well-established, the physiological role of GnRH-II is less clear. Both forms of GnRH are highly expressed in the monkey hypothalamus and both forms are highly effective at stimulating LH and FSH release in vivo. However, estradiol appears to affect GnRH-I and GnRH-II gene expression diff...